Bipolar Disorder Trial, Recruiting NCT06134349 Sponsor: Leiden University Medical Center Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06134349
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been clinically diagnosed with bipolar disorder type I or type II
  • People whose lithium levels in the blood have reached a stable therapeutic range (0.6–1.0 mM for those under 65, or 0.4–0.8 mM for those aged 65 and over) within the four weeks before joining the study
  • People who have provided written consent to participate

Who may not be able to join:

  • People who do not have sufficient understanding of the Dutch language
  • People who are unable to give informed consent to participate
  • People who have used drugs or alcohol excessively in the two weeks before joining the study
  • People who have any medical or safety reason that would prevent them from having an MRI scan (confirm with trial site for specific details)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: E Boere, MD, Leiden University Medical Center

Phone: +31(0)715263785

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Leiden University Medical Center
Registry
ClinicalTrials.gov
Start date
13 March 2024
Est. completion
1 March 2027

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Clinical lithium response

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov